Annemarie Stroustrup: Hospital-based Phthalate Exposure and Chronic Lung Disease of Prematurity

Key Takeaways:

• Preterm infants are at an increased risk for a variety of adverse health outcomes, but these outcomes cannot be consistently predicted by factors like gestational age or birth weight.
• Phthalates are found in many of the medical devices and products used in neonatal intensive care units (NICUs) to care for preterm infants.
• Bronchopulmonary Dysplasia (BPD) is a developmental disease of preterm infants that occurs when the baby’s lungs are unable to develop correctly, often due to trauma caused by breathing support apparatuses.
• The ECHO Developmental Impact of NICU Exposures (DINE) Study—a collaboration of four preterm birth cohorts—suggest that exposure to specific phthalate mixtures at certain susceptible points in preterm infant development are linked with BPD diagnosis, even when adjusting for the use of breathing support apparatuses.

Speaker:

Annemarie Stroustrup, MD, MPH

Cohen Children’s Medical Center
Northwell Health, NY

Speaker Bio:

Dr. Stroustrup is the System Chief of Neonatology, Vice President and Director of Neonatal Services for Northwell Health. She completed her undergraduate studies at Princeton University, medical school at Harvard Medical School and the Massachusetts Institute of Technology, and public health training at the Icahn School of Medicine at Mount Sinai. In addition to providing clinical care and leadership, Dr. Stroustrup’s research focuses on reducing modifiable hospital-based environmental factors that impact the long-term health and development of preterm infants. When not working to make the NICU a safer place for small baby development, Dr. Stroustrup enjoys running half marathons and spending time with her four children and husband at their home in Harlem, New York City.

Date: Wednesday, January 11th, 1 to 2pm ET